Pfizer Inc. (PFE) — closed signal from December 13, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on March 13, 2026.
Predicted vs. what happened
What happened
Hit or exceeded the predicted growth inside the window.
The thesis — published December 13, 2025
Pfizer looks like a recovery trade that also pays income. The board approved a $0.43 quarterly dividend (about 6.7% yield), which gives investors steady cash and can make people buy when the stock falls. Price behavior has recently improved, but the case for big gains rests more on mood and the payout than on clear, fast revenue growth. Near-term the main play is earning the dividend while hoping valuation steadies.
Primary drivers
- Dividend gives steady cash and supports buying on dips
- New drug programs (flu, cancer, obesity) can improve sentiment
- Recent price action looks like it's finding a floor after a long drop
- Seen as cheap by some investors who are shifting into healthcare
How it played out
PFE: thesis rose but target was not reached
Lyra published PFE at $25.85 on 2025-12-13 as a short-term recovery and income thesis. It expected 10% growth to $28.44. The thesis pointed to the $0.43 quarterly dividend, about a 6.7% yield, steadier recent price action, new drug programs in flu, cancer, and obesity, and investors viewing healthcare as cheap.
Inside the window, PFE rose to $27.94 on 2026-02-11, a peak gain of 8.1%. It stayed below the $28.44 target. By 2026-03-13 it ended at $26.58. The thesis partially played out, but it did not reach the published target.
What happened during the window
On Feb. 3, 2026, Pfizer reported fourth-quarter sales of $17.56 billion and adjusted earnings of $0.66 per share. The company also reported PF-3944 trial data showing 12.3% placebo-adjusted weight loss at 28 weeks.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.